Table 1 Data from cross-sectional and longitudinal studies used for model calibration

From: Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax

Location

Study period

Age (years)

PCR

LM

Clinical

Reference

Cross-sectional data

      

 Ngella, Solomon Islands

2012

18 (0.5, 100)

468/3501

127/3501

15/3501

Waltmann61

 PNG; >1500 m

2000/02

16 (0.4, 77)

 

32/664

5/664

Senn62

 PNG; 1000–1500 m

 

17 (0.6, 95)

 

217/2835

35/2835

Senn62

 PNG; 500–1000 m

 

19 (0.0, 87)

 

446/9030

93/9030

Senn62

 PNG; 0–500 m

 

22 (0.1, 99)

 

290/9943

109/9943

Senn62

 Wosera, East Sepik

1991/92, 1998/99, 2001/03

17 (0.1, 80)

901/2527

368/2527

24/2527

Mueller63

 Wosera, East Sepik

1991/92

17.4 (0.1, 87)

 

1207/6782

 

Genton64

 Wosera, East Sepik

2001/03

17 (0.1, 99)

 

1639/15737

 

Kasehagen65

 Madang

2006

14.2 (0.0, 72)

 

204/1227

22/1227

Koepfli66

 Ilaita & Sunuhu

2006

1.7 (0.8, 3.2)

1433/2129

1092/2129

133/2129

Lin67

Longitudinal data

      

 Mugil, Madang

2004

9.3 (4.8, 14.4)

192/204

139/204

10/204

Michon68

 Albinama, East Sepik (placebo arm)

2008/09

7.6 (4.8, 10.4)

179/257

132/257

22/257

Robinson10

 Albinama, East Sepik (primaquine arm)

2008/09

7.5 (4.9, 10.4)

69/247

45/247

9/247

Robinson10

 Wosera, East Sepik

1998/99

16 (0.1, 85)

 

686/1689

 

Kasehagen69

  1. Age is presented as median with range. Samples were tested for parasitaemia by PCR or light microscopy, or for a clinical case of P. vivax if accompanied by fever in the last 48 h
  2. n/N denotes n positive out of N samples